MedTech 101

Send us a Message Ever applied for a job and heard nothing back? You're not alone. 1 in 4 applications right now is a bot, and most companies don't have time to go through 500 applicants. In this episode, medtech recruitment specialist Chay Carter breaks down why the system is broken, what top companies are actually looking for, and how platforms like Reccy Neuro are trying to fix it. Whether you're a student, early career, or looking to break into neurotech or medtech this one's for you.Timestamp:00:00 Introduction 03:03 Che Carter's background – psychology to banking to neurotech 04:50 Building the Reki Neuro ecosystem – newsletter to job platform 11:01 The neurotech spectrum – implantables, wearables, BCIs 13:15 The bot problem – 1 in 4 applications may be automated 14:20 Newsletter and job board integration 15:24 Candidate matching platform – 70%+ score filtering 19:19 Funding challenges limiting medtech hiring 20:50 Geographic talent hubs – Bay Area, Austin, New York 21:28 Career advice – start at large firms before startups 27:00 The niche ecosystem vision – rebuilding early LinkedIn for medtech 27:20 LinkedIn's decline for focused recruitment 29:28 AI's role in recruitment – helps recruiters, not candidates 31:00 Open access and community growth strategyLinks: Reccy Neuro: https://www.reccy.dev/Newsletter: https://theneurotechnewsletter.substack.com/Heres the specific article: https://theneurotechnewsletter.substack.com/p/the-reemergence-of-eeg-why-the-brainSupport the showFollow or Connect with Rodney Moses:Instagram | LinkedIn | YouTube | Donations Patreon | PayPal

Send us a Message In this first MedTech 101 episode of the year, Rodney Moses explores where MedTech is heading in 2026 and beyond. Drawing from industry history, market data, and real-world regulatory experience, he identifies three key growth pillars shaping the future of healthcare: telemedicine, artificial intelligence, and personalised medicine.Using Intuitive Surgical as a case study, Rodney explains how patents, monopolies, and regulation influence innovation and market expansion. He then breaks down why telemedicine is accelerating rapidly, how AI is enhancing (not replacing) clinicians, and why personalised medicine is set to become a trillion-dollar market.This episode offers a clear investment, innovation, and career lens on where MedTech is moving—and where attention should be focused over the next five years.⏱️ Episode Time-Step Summary (Chapters)(0:00–0:20) High-Growth MedTech ThesisMedTech companies operating in telemedicine, AI, and personalised medicine are positioned for strong long-term growth.(0:20–1:55) Welcome & Podcast UpdateRodney Moses welcomes listeners to the first episode of the year, reflects on fewer episodes in 2025, and shares updates on starting postgraduate studies in Munich and expanding the podcast’s scope.(1:55–2:23) Framing the Future of MedTechTo predict the future of MedTech, we must first understand the present and recent history of the industry.(2:23–4:08) Intuitive Surgical & Market EvolutionIntuitive Surgical’s early patents created a long-lasting monopoly in surgical robotics. Patent expiry enabled competitors, lowered regulatory barriers, and expanded the market.(4:08–4:59) Innovation, Patents & RegulationDiscussion on balancing patent protection, innovation incentives, affordability, and the role of regulation in MedTech markets.(4:59–6:35) Telemedicine: Market Growth & ImpactTelemedicine as a key future pillar of MedTech, driven by wearables and remote monitoring.Market size: $141B (2024) → $380B (2030)Benefits include hospital decongestion and improved access to care.(6:35–10:00) Artificial Intelligence in MedTechAI as an enabler rather than a replacement for doctors. Use cases include diagnostics, imaging, mental health analysis, and decision support.Market size: $14B (2024) → $255B (2033)Regulatory catch-up remains a challenge, but momentum is strong.(10:06–11:22) Personalised Medicine & Data-Driven CareShift from generalized treatments to tailored therapies based on individual patient data, improving efficacy and outcomes.(11:22–11:54) Personalised Medicine Market OutlookOne of the fastest-growing healthcare markets globally.Market size: $567B (2024) → $1.2T (2033)(11:54–12:57) Where to Focus in MedTechThe three strongest growth areas for the next 1–5 years:TelemedicineArtificial IntelligencePersonalised MedicineSurgical robotics remains important but secondary in near-term growth.(12:57–13:11) Closing RemarksRodney thanks listeners, marks his return to the podcast, and invites guest and topic suggestions.Support the showFollow or Connect with Rodney Moses:Instagram | LinkedIn | YouTube | Donations Patreon | PayPal

Send us a Message In this compelling episode of MedTech 101, host Rodney Moses sits down with RenovoRx CEO Shaun Bagai to explore the latest breakthroughs in cancer treatment. The conversation opens with a clear-eyed look at the challenges pancreatic cancer patients face, before diving into Shaun’s remarkable journey—from aspiring pre-med student to seasoned medtech leader—and the pivotal role engineering plays in redefining cancer care.Rodney underscores the importance of pairing technological innovation with true patient-centric thinking, setting the tone for an insightful discussion on medtech’s ability to transform lives.Shaun explains how RenovoRx is changing the treatment landscape through its patented localized therapy platform, designed to deliver chemotherapy directly to the tumor while reducing life-limiting systemic side effects. Their discussion highlights the development and impact of the RenovoCath catheter and the Trans-Arterial Micro-Perfusion (TAMP) system, technologies that enable precise, targeted drug delivery and bring renewed hope for improved outcomes.Rodney and Shaun also touch on the contrast between the agility of startups and the slower pace of traditional medtech companies—using RenovoRx’s journey to a NASDAQ listing, without being acquired by a larger player, as a powerful example of strategic independence. The episode wraps with optimism about the future of oncology and the transformative potential of smarter drug-delivery systems.Timestamp Summary 00:00 | Innovative Approach to Treating Pancreatic Cancer Locally01:50 | Renovo Rx's Innovative Approach to Localized Chemotherapy Delivery02:31 | From Medtronic to CEO: A Journey in Medical Innovation05:28 | Leveraging Technology in Medicine for Widespread Impact06:47 | RenovoRx's Unique Path in the Medtech Industry12:39 | Innovative Localized Chemotherapy for Pancreatic Cancer Treatment19:22 | Expanding Life-Saving Technology Beyond the US Market21:02 | Innovative Delivery Systems for Pancreatic Cancer TreatmentSupport the showFollow or Connect with Rodney Moses:Instagram | LinkedIn | YouTube | Donations Patreon | PayPal

Send us a Message Viral Thakkar, COO of LungPacer Medical, joins Rodney on the MedTech 101 Podcast to discuss how cutting-edge innovation is reshaping ventilator technology. They unpack the limitations of traditional mechanical ventilation and its often-overlooked effects on the diaphragm. Viral shares insights into AeroPace, LungPacer’s breakthrough system that uses phrenic nerve stimulation to help patients breathe and recover more effectively.The discussion dives into the real-world challenges of clinical adoption, the significance of FDA Breakthrough Designation, and what the future holds for ventilation care. Tune in to learn how this technology could redefine outcomes for ICU patients by reducing complications and accelerating recovery.Timestamp00:00 The Impact of Mechanical Ventilation on Diaphragm Health02:02 From R&D to COO: Viral Thakkar's Medtech Journey03:20 A Journey from Personal Tragedy to Medical Device Innovation05:56 Ventilator-Induced Diaphragm Dysfunction and Its Consequences11:38 Innovative Diaphragm Stimulation Technology for Improved Ventilation15:45 Breakthrough Medical Device Designation and Market Challenges19:27 Innovative Ventilation Technology Aims to Improve ICU Patient OutcomesSupport the showFollow or Connect with Rodney Moses:Instagram | LinkedIn | YouTube | Donations Patreon | PayPal

Send us a Message Ben Tasker, is an AI expert who has transitioned from academia to the utilities sector, focusing on upskilling and reskilling the workforce for the AI era. He discusses his experience developing AI systems for student success prediction in education and cancer risk identification in healthcare.The core themes are:The importance of responsible and ethical AI practices as the technology rapidly advancesThe challenges of getting buy-in from end-users (students, patients, employees) and integrating AI into existing workflowsThe potential of AI to enable more personalized services, especially in healthcare and mental healthThe need to balance the benefits of AI-powered personalization with concerns around privacy, transparency, and the risk of reinforcing biasesOverall, Ben emphasizes the critical role of human-centered design and stakeholder engagement in ensuring AI is implemented effectively and ethically across different industries.Support the showFollow or Connect with Rodney Moses:Instagram | LinkedIn | YouTube | Donations Patreon | PayPal

Send us a Message Dr Kevin Tracey is a renowned neurosurgeon and the president of the Feinstein Institutes for Medical Research. With over three decades of experience focused on understanding and controlling inflammation. Dr Tracey has pioneered research that led to advancements in bioelectronic medicine. His work explores the potential of the vagus nerve to regulate inflammation, paving the way for innovative treatments for chronic conditions like rheumatoid arthritis. Kevin is also a co-founder of SetPoint Medical, which recently received FDA approval for an implant device aimed at treating inflammation.Timestamp00:00 Bioelectronic Devices Revolutionize Inflammation Treatment04:28 Exploring Bioelectronic Medicine and Innovative Medical Research09:09 Vagus Nerve Stimulation as a Breakthrough in Inflammation Treatment13:07 Implant Revolutionizes Rheumatoid Arthritis Treatment15:56 Vagus Nerve Stimulation and Its Role in Inflammation Control20:25 SetPoint Medical's FDA Approval and Future Distribution Challenges24:08 The Promise of Vagus Nerve Stimulation for Rheumatoid Arthritis27:29 Understanding Present Data to Predict Future Technological Advancements29:48 Vagus Nerve Stimulation as a Future Inflammation Treatment32:16 Podcast Interview with Author Kevin TraceyBook: The Great Nerve: The New Science of the Vagus Nerve and How to Harness Its Healing Reflexes Support the showFollow or Connect with Rodney Moses:Instagram | LinkedIn | YouTube | Donations Patreon | PayPal

Send us a Message In this episode of the MedTech 101 podcast, host Rodney Moses sits down with Erin Lee, CEO of Flow Neuroscience, to talk about how technology is changing the way we treat mental health.Erin shares the story behind Flow’s groundbreaking device that uses gentle brain stimulation to treat depression, without relying on traditional antidepressants. Together, they discuss the challenges of drug-based therapies and Flow’s mission to make mental health treatment more effective, affordable, and accessible.Erin also opens up about her unconventional journey into medtech, from her time at leading tech firms to her eye-opening experience at Babylon Health, which shaped her vision for digital health innovation.The conversation dives into how Flow operates as a Scandinavian company with a global footprint, spanning the UK, EU, and now expanding into the U.S. market. Erin explains the regulatory hurdles they face, how they navigate them, and what it takes to bring such a device to different regions.She also talks about Flow’s wearable headset — a clinically proven, non-drug treatment that uses targeted electrical stimulation to improve mood. Finally, Erin reflects on the future of mental health care, where AI and medtech could work together to deliver more personalized and accessible treatments for people everywhere.Timestamp00:00 Revolutionizing Depression Treatment Without Antidepressants01:44 Erin Lee's Unconventional Journey to Leading Flow Neuroscience06:07 Innovative Headset Offers Drug-Free Depression Treatment12:17 Challenges and Strategies in Medical Device Market Approvals15:53 Challenges in Introducing Innovative Medical Devices to the Market22:41 The Future of Personalized Brain Stimulation for Depression Treatment29:31 Erin Lee Discusses Neuroscience and Upcoming Device LaunchSupport the showFollow or Connect with Rodney Moses:Instagram | LinkedIn | YouTube | Donations Patreon | PayPal

Send us a Message In this episode, Rodney sits down with Henry O’Connell, co-founder of Canary Speech, to explore how vocal biomarkers are changing the way we understand health. From detecting anxiety and depression to assessing cognitive function, Canary Speech’s approach breaks through language barriers and gives clinicians clearer insights into patient care. Together, Rodney and Henry discuss how this innovation could open the door to more accessible healthcare—from Utah to the most remote corners of the world.Timestamp00:00 Canary Speech and the Future of Vocal Biomarkers07:23 Understanding Emotional Cues in Family Interactions10:16 Revolutionizing Healthcare with Ambient Listening and AI Analysis22:54 Understanding Vocal Cords and Emotional Speech Patterns25:31 AI Revolutionizing Mental Health Diagnosis and Treatment33:09 Leveraging Technology to Equalize Global Healthcare Access38:31 Connecting with Henry O'Connell Through LinkedIn and EmailSupport the showFollow or Connect with Rodney Moses:Instagram | LinkedIn | YouTube | Donations Patreon | PayPal

Send us a Message In this enlightening episode of the MedTech 101 podcast, host Rodney introduces the unique and transformative work of Sinan Golhan, CEO of Geltech, who is at the forefront of advancing hydrogel technology. Hydrogels have the extraordinary capacity to absorb up to 10,000 times their weight in water, making them invaluable across diverse fields such as medtech, pharmaceuticals, and even cosmetics. This episode unravels how Geltech is making significant strides in streamlining hydrogel research through automation, reducing the cost of testing and accelerating the timeline for hydrogel innovations to benefit various industries.As the discussion progresses, Sinan shares his personal journey from UC San Diego to founding Geltech. Motivated by a poignant family health challenge, Sinan's quest has been to enhance the precision of cancer treatments via hydrogels. Throughout this conversation, Sinan delves deep into the hurdles of fundraising and the scalable solutions devised by Geltech to expedite and automate the labor-intensive process of hydrogel testing. Listeners gain an insight into the potential futureTimestamp00:00 Innovative Hydrogel Applications in MedTech and Pharmaceuticals03:14 Innovating Cancer Treatment Through Robotics and Personal Motivation05:29 Hydrogels: Transformative Applications in Medicine and Biotechnology08:28 Revolutionizing Hydrogel Testing with Automated Lab Technology15:45 Challenges and Strategies in Raising Capital for Startups17:30 Unexpected Networking Leads to Successful Startup Fundraising23:17 The Future of 3D-Printed Hydrogels in MedTechGelTech https://www.geltechlabs.comSupport the showFollow or Connect with Rodney Moses:Instagram | LinkedIn | YouTube | Donations Patreon | PayPal

Dr. Elliot Justin, a pioneering doctor and founder of FirmTech, delves into men's health and innovative wearable technology. He unveils the tech ring designed to enhance erectile performance while monitoring cardiovascular health. The conversation explores overlooked causes of erectile dysfunction, the crucial role of testosterone, and the evolution of sex tech as essential health tools rather than mere pleasure devices. Dr. Justin shares insights on regulatory challenges and the importance of data in promoting men's health awareness.